DNMT3A and neoplasm: In contrast, Kodada et al. [111] identified DNMT3A and TET2 mutations in ctDNA from peripheral plasma that were absent in tumor tissue, indicating challenges in distinguishing tumor-specific mutations from age-related clonal hematopoiesis (ARCH).